anticancer drugs
Showing 1 - 25 of >10,000
Acute Cardiovascular Adverse Events Occuring in Children Treated
Not yet recruiting
- Malignancies
- +2 more
- use of anticancer drugs in monotherapy or in combination therapy
- (no location specified)
Oct 27, 2022
Renal Cell Carcinoma, Ovarian Carcinoma, Thyroid Carcinoma Trial in Groningen (Olaparib, Lenvatinib, Sunitinib)
Not yet recruiting
- Renal Cell Carcinoma
- +4 more
- Olaparib
- +4 more
-
Groningen, NetherlandsUniversity Medical Center Groningen
Jul 13, 2023
Multidisciplinary Care Program to Secure mEdication Therapy for
Not yet recruiting
- Chemotherapy Effect
- +2 more
- Assessment of patient satisfaction regarding tele-consultation
- +4 more
-
Pierre-Bénite, FranceHôpital Lyon Sud - Hospices Civils de lyon
Apr 22, 2022
Breast Cancer Trial in Seoul (Extracorporeal shock waves)
Recruiting
- Breast Cancer
- Extracorporeal shock waves
-
Seoul, Yangcheon Gu, Korea, Republic ofKiwhan Kim
Oct 25, 2022
Cancer Trial in Pierre-Bénite (The DROP program of pharmaceutical interventions, Standard of care)
Recruiting
- Cancer
- The DROP program of pharmaceutical interventions
- Standard of care
-
Pierre-Bénite, FranceService pharmaceutique, Unité de Pharmacie Clinique Oncologique,
Oct 28, 2021
Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Refractory Malignant Solid Tumor Trial in Boston, Galveston,
Suspended
- Advanced Malignant Solid Neoplasm
- +4 more
- BET Bromodomain Inhibitor ZEN-3694
- Binimetinib
-
Boston, Massachusetts
- +2 more
Oct 5, 2022
Clinical Stage III Merkel Cell Carcinoma AJCC v8, Clinical Stage IV Merkel Cell Carcinoma AJCC v8, Locally Advanced Merkel Cell
Not yet recruiting
- Clinical Stage III Merkel Cell Carcinoma AJCC v8
- +5 more
- Avelumab
- +6 more
- (no location specified)
Jul 13, 2023
Cancer, Oral Anticancer Drugs Trial in France (PRESTAGE)
Recruiting
- Cancer
- Oral Anticancer Drugs
- PRESTAGE
-
Bron, France
- +8 more
May 23, 2022
Glioblastoma Trial in Ulm (Temozolomide, Aprepitant, Minocycline)
Completed
- Glioblastoma
- Temozolomide
- +9 more
-
Ulm, Baden-Württemberg, GermanyUniversity of Ulm School of Medicine
Oct 4, 2021
BTK Inhibitors-related AF Treated by Catheter Ablation
Not yet recruiting
- BTKi-induced Atrial Fibrillation
- +2 more
- Atrial fibrillation catheter ablation in a population of BTKi-induced atrial fibrillation
-
Caen, Normandy, FranceCaen University Hospital
Nov 10, 2023
Preventing and Treating Cardiotoxicity Induced by Anticancer
Recruiting
- Cardiovascular Complication
- +7 more
- Anti-Cancer Agents
-
Paris, France
- +2 more
Sep 24, 2019
Preferences of Patients Treated With Oral Cancer Drugs and
Not yet recruiting
- Preference, Patient
- +3 more
-
Besançon, FranceCHU de Besançon
Jul 24, 2023
Vincristine-induced Peripheral Neuropathy in Adult Survivors of
Not yet recruiting
- Chemotherapy-induced Peripheral Neuropathy
- self-administered questionnaire
- (no location specified)
Feb 24, 2023
Oral Cancer Trial in Cairo (Quercetin 3,3',4',5,6-Pentahydroxyflavone,
Not yet recruiting
- Oral Cancer
- Quercetin 3,3',4',5,6-Pentahydroxyflavone, 2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-1-benzopyran-4-one
- +2 more
-
Cairo, Egypt11 Saraya El Manial
Jul 8, 2022
COVID-19 Pandemic on Drug Use and Monitoring of Cancer Patients
Completed
- Cancer
- Directive Interview
-
Pierre-Bénite, FranceService Pharmaceutique, Hospices Civils de Lyon
Jan 7, 2022
Acute Erythroid Leukemia, Acute Lymphoblastic Leukemia, Acute Megakaryoblastic Leukemia Trial in United States (drug, radiation,
Recruiting
- Acute Erythroid Leukemia
- +10 more
- Fludarabine
- +5 more
-
San Francisco, California
- +5 more
Nov 1, 2022
Cancer, Drug Toxicity, Atrial Fibrillation Trial in Caen (occurence of atrial fibrillation)
Recruiting
- Cancer
- +3 more
- occurence of atrial fibrillation
-
Caen, Normandy, FranceAlexandre
Jul 6, 2022
Advanced Cancer, Solid Tumor Trial in Helsinki, Kuopio, Tampere (Alectinib, Cobimetinib, Vismodegib)
Recruiting
- Advanced Cancer
- Solid Tumor
- Alectinib
- +13 more
-
Helsinki, Uusimaa, Finland
- +2 more
Jun 8, 2022
Early Hormone Receptor-positive Breast Cancer Trial in Seoul (Chemotherapy Drugs, Cancer)
Recruiting
- Early Hormone Receptor-positive Breast Cancer
- Chemotherapy Drugs, Cancer
-
Seoul, Korea, Republic ofSamsung Medical Center
Feb 19, 2020
Solid Tumor Regarding Access to Dermo-cosmetics and Aesthetic
Not yet recruiting
- Neoplasms
- Questionnaires
-
Strasbourg, FranceInstitut de cancérologie Strasbourg Europe
Jun 16, 2023
Rivaroxaban and Apixaban in Cancer Patients
Recruiting
- Anticoagulants and Thrombotic Disorders
- Monitoring
-
Paris, FranceCentre d'Investigation Clinique Hôpital Pitié-Salpêtrière
Apr 20, 2023
Cancer Target Therapy Efficacy
Active, not recruiting
- Cancer
- RNA sequencing
- +5 more
-
Walnut, California
- +6 more
Sep 13, 2021
Solid Organ Malignancies, Adenoidcystic Carcinoma, Neuroendocrine Tumors Trial in Atlanta (Lenalidomide, Everolimus)
Completed
- Solid Organ Malignancies
- +2 more
-
Atlanta, Georgia
- +1 more
Nov 19, 2021
Hepatocellular Carcinoma, Colorectal Cancer Trial in Hong Kong (Patient-Derived Tumor Organoids)
Not yet recruiting
- Hepatocellular Carcinoma
- Colorectal Cancer
- Patient-Derived Tumor Organoids
-
Hong Kong, N.t., Hong KongEndoscopy Centre, Prince of Wales Hospital
Oct 12, 2023
Hodgkin Lymphoma Trial in Worldwide (brentuximab vedotin, doxorubicin, vinblastine)
Active, not recruiting
- Hodgkin Lymphoma
- brentuximab vedotin
- +5 more
-
Fountain Valley, California
- +75 more
Dec 2, 2022